Epidemiology and the Evidence-Based Medicine Approach

Withrow and MacEwen's Small Animal Clinical Oncology: Fifth Edition

Volumn , Issue , 2012, Pages 68-82

  Butler, Lesley M ^a   Bonnett, Brenda N ^b   Page, Rodney L ^a,c  

^a Department of Ecosystem Science and Sustainability   (United States)

^b B Bonnett Consulting   (Canada)

^c Flint Animal Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884489619     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2362-5.00004-9     Document Type: Chapter

References (108)

1. Sargeant JM, O'Connor AM, Gardner IA, et al. The REFLECT statement: reporting guidelines for randomized controlled trials in livestock and food safety: explanation and elaboration. J Food Prot 2010, 73(3):579-603.
2. O'Connor AM, Sargeant JM, Gardner IA, et al. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety. J Food Prot 2010, 73(1):132-139.
3. Rishniw M, Pion PD, Herndon WE, et al. Improving reporting of clinical trials in veterinary medicine. J Vet Intern Med 2010, 24(4):799-800. Author reply 1-2.
4. Hinchcliff KW, DiBartola SP Quality matters: publishing in the era of CONSORT, REFLECT, and EBM. J Vet Intern Med 2010 Jan-F, 24(1):8-9.
5. Merlo DF, Rossi L, Pellegrino C, et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. J Vet Intern Med 2008, 22(4):976-984.
6. Vascellari M, Baioni E, Ru G, et al. Animal tumour registry of two provinces in northern Italy: incidence of spontaneous tumours in dogs and cats. BMC Vet Res 2009, 5:39.
7. Bronden LB, Nielsen SS, Toft N, et al. Data from the Danish veterinary cancer registry on the occurrence and distribution of neoplasms in dogs in Denmark. Vet Rec 2010, 166(19):586-590.
8. Moe L, Gamlem H, Dahl K, et al. Canine neoplasia-population-based incidence of vascular tumours. APMIS Suppl 2008, 125:63-68.
9. Nodtvedt A, Gamlem H, Gunnes G, et al. Breed differences in the proportional morbidity of testicular tumours and distribution of histopathologic types in a population-based canine cancer registry. Vet Comp Oncol 2011, 9(1):45-54.
10. Moe L, Bredal WP, Glattre E Census of dogs in Norway 2001, Norwegian School of Veterinary Science, Oslo, (ISBN 82-7725-062-2).
11. Dorn CR, Taylor DO, Frye FL, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases. J Natl Cancer Inst 1968, 40(2):295-305.
12. Dorn CR, Taylor DO, Schneider R, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968, 40(2):307-318.
13. Priester WA, McKay FW The occurrence of tumors in domestic animals. Natl Cancer Inst Monogr 1980, 54:1-210.
14. Bronden LB, Flagstad A, Kristensen AT Veterinary cancer registries in companion animal cancer: a review. Vet Comp Oncol 2007, 5(3):133-144.
15. Nødtvedt A, Berke O, Bonnett BN, et al. Current status of canine cancer registration: Report from an international workshop. Vet Comp Oncol 2011, doi: 10.1111/j.1476-5829.2011.00279.x.
16. MacVean DW, Monlux AW, Anderson PS, et al. Frequency of canine and feline tumors in a defined population. Vet Pathol 1978, 15(6):700-715.
17. Nødtvedt A, Berke O, Bonnett BN, et al. Current status of canine cancer registration: Report from an international workshop. Vet Comp Oncol 2011, doi: 10.1111/j.1476-5829.2011.00279.x epub ahead of print.
18. Craig LE Cause of death in dogs according to breed: a necropsy survey of five breeds. J Am Anim Hosp Assoc 2001, 37(5):438-443.
19. Fleming JM, Creevy KE, Promislow DE Mortality in north american dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death. J Vet Intern Med 2011, 25(2):187-198.
20. Bonnett BN, Egenvall A, Hedhammar A, et al. Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed-, gender-, age- and cause-specific rates. Acta Vet Scand 2005, 46(3):105-120.
21. Veterinary Medical Database (VMDB) accessed: 06/08/2011. http://www.vmdb.org.
22. Bartlett PC, Van Buren JW, Neterer M, et al. Disease surveillance and referral bias in the veterinary medical database. Prev Vet Med 2010, 94(3-4):264-271.
23. Dobson JM, Samuel S, Milstein H, et al. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract 2002, 43(6):240-246.
24. Egenvall A, Hedhammar A, Bonnett BN, et al. Survey of the Swedish dog population: age, gender, breed, location and enrollment in animal insurance. Acta Vet Scand 1999, 40(3):231-240.
25. Egenvall A, Bonnett BN, Hedhammar A, et al. Mortality in over 350,000 insured Swedish dogs from 1995-2000: II. Breed-specific age and survival patterns and relative risk for causes of death. Acta Vet Scand 2005, 46(3):121-136.
26. Egenvall A, Nodtvedt A, Penell J, et al. Insurance data for research in companion animals: benefits and limitations. Acta Vet Scand 2009, 51:42.
27. Egenvall A, Nodtvedt A, von Euler H Bone tumors in a population of 400000 insured Swedish dogs up to 10 y of age: incidence and survival. Can J Vet Res 2007, 71(4):292-299.
28. Egenvall A, Bonnett BN, Ohagen P, et al. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 2005, 69(1-2):109-127.
29. Egenvall A, Nodtvedt A, Haggstrom J, et al. Mortality of life-insured Swedish cats during 1999-2006: age, breed, sex, and diagnosis. J Vet Intern Med 2009, 23(6):1175-1183.
30. Egenvall A, Bonnett BN, Haggstrom J, et al. Morbidity of insured Swedish cats during 1999-2006 by age, breed, sex, and diagnosis. J Feline Med Surg 2010, 12(12):948-959.
31. Rissetto K, Villamil JA, Selting KA, et al. Recent trends in feline intestinal neoplasia: an epidemiologic study of 1,129 cases in the veterinary medical database from 1964 to 2004. J Am Anim Hosp Assoc 2011, 47(1):28-36.
32. Hayes HM, Milne KL, Mandell CP Epidemiological features of feline mammary carcinoma. Vet Rec 1981, 108(22):476-479.
33. Stovring M, Moe L, Glattre E A population-based case-control study of canine mammary tumours and clinical use of medroxyprogesterone acetate. APMIS 1997, 105(8):590-596.
34. Marconato L, Leo C, Girelli R, et al. Association between waste management and cancer in companion animals. J Vet Intern Med 2009, 23(3):564-569.
35. Glickman LT, Raghavan M, Knapp DW, et al. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 2004, 224(8):1290-1297.
36. Weeth LP, Fascetti AJ, Kass PH, et al. Prevalence of obese dogs in a population of dogs with cancer. Am J Vet Res 2007, 68(4):389-398.
37. Paluszkiewicz P, Smolinska K, Debinska I, et al. Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies. Cancer Epidemiol 2011 Oct 20.
38. Sun CL, Yuan JM, Koh WP, et al. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 2006, 27(7):1310-1315.
39. Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011, 343. d6617.
40. Reif JS, Bruns C, Lower KS Cancer of the nasal cavity and paranasal sinuses and exposure to environmental tobacco smoke in pet dogs. Am J Epidemiol 1998, 147(5):488-492.
41. Reif JS, Dunn K, Ogilvie GK, et al. Passive smoking and canine lung cancer risk. Am J Epidemiol 1992, 135(3):234-239.
42. Bertone ER, Snyder LA, Moore AS Environmental tobacco smoke and risk of malignant lymphoma in pet cats. Am J Epidemiol 2002, 156(3):268-273.
43. Bertone ER, Snyder LA, Moore AS Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. J Vet Intern Med 2003, 17(4):557-562.
44. Hayes HM, Tarone RE, Cantor KP, et al. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst 1991, 83(17):1226-1231.
45. Glickman LT, Schofer FS, McKee LJ, et al. Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J Toxicol Environ Health 1989, 28(4):407-414.
46. Raghavan M, Knapp DW, Dawson MH, et al. Topical flea and tick pesticides and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 2004, 225(3):389-394.
47. Bettini G, Morini M, Marconato L, et al. Association between environmental dust exposure and lung cancer in dogs. Vet J 2010, 186(3):364-369.
48. Gavazza A, Presciuttini S, Barale R, et al. Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners. J Vet Intern Med 2001 May-J, 15(3):190-195.
49. Bukowski JA, Wartenberg D, Goldschmidt M Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk. J Toxicol Environ Health A 1998, 54(7):579-591.
50. Sonnenschein EG, Glickman LT, Goldschmidt MH, et al. Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am J Epidemiol 1991, 133(7):694-703.
51. Ru G, Terracini B, Glickman LT Host related risk factors for canine osteosarcoma. Vet J 1998, 156(1):31-39.
52. Dias Pereira P, Lopes CC, Matos AJ, et al. Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors. Vet Pathol 2009, 46(6):1270-1274.
53. Cooley DM, Beranek BC, Schlittler DL, et al. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002, 11(11):1434-1440.
54. Teske E, Naan EC, van Dijk EM, et al. Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrinol 2002, 197(1-2):251-255.
55. Bryan JN, Keeler MR, Henry CJ, et al. A population study of neutering status as a risk factor for canine prostate cancer. Prostate 2007, 67(11):1174-1181.
56. Misdorp W, Romijn A, Hart AA Feline mammary tumors: a case-control study of hormonal factors. Anticancer Res 1991, 11(5):1793-1797.
57. Overley B, Shofer FS, Goldschmidt MH, et al. Association between ovarihysterectomy and feline mammary carcinoma. J Vet Intern Med 2005, 19(4):560-563.
58. Perez Alenza D, Rutteman GR, Pena L, et al. Relation between habitual diet and canine mammary tumors in a case-control study. J Vet Intern Med 1998, 12(3):132-139.
59. Raghavan M, Knapp DW, Bonney PL, et al. Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 2005, 227(1):94-100.
60. Kass PH, Spangler WL, Hendrick MJ, et al. Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 2003, 223(9):1283-1292.
61. Kass PH, Barnes WG, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993, 203(3):396-405.
62. Hutson CA, Rideout BA, Pedersen NC Neoplasia associated with feline immunodeficiency virus infection in cats of southern California. J Am Vet Med Assoc 1991, 199(10):1357-1362.
63. Gabor LJ, Love DN, Malik R, Canfield PJ Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Aust Vet J 2001, 79(8):540-545.
64. Shelton GH, Grant CK, Cotter SM, et al. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquir Immune Defic Syndr 1990, 3(6):623-630.
65. Dorn CR, Taylor DO, Schneider R Sunlight exposure and risk of developing cutaneous and oral squamous cell carcinomas in white cats. J Natl Cancer Inst 1971, 46(5):1073-1078.
66. Backer LC, Grindem CB, Corbett WT, et al. Pet dogs as sentinels for environmental contamination. Sci Total Environ 2001, 274(1-3):161-169.
67. Reif JS Animal sentinels for environmental and public health. Public Health Rep 2011, 126(Suppl 1):50-57.
68. Kelsey JL, Moore AS, Glickman LT Epidemiologic studies of risk factors for cancer in pet dogs. Epidemiol Rev 1998, 20(2):204-217.
69. Hernandez JA, Anderson AE, Holmes WL, et al. Pulmonary parenchymal defects in dogs following prolonged cigarette smoke exposure. Am Rev Respir Dis 1966, 93(1):78-83.
70. Cross FT, Palmer RF, Filipy RE, et al. Carcinogenic effects of radon daughters, uranium ore dust and cigarette smoke in beagle dogs. Health Phys 1982, 42(1):33-52.
71. Dich J, Zahm SH, Hanberg A, et al. Pesticides and cancer. Cancer Causes Control 1997, 8(3):420-443.
72. Hardell L Pesticides, soft-tissue sarcoma and non-Hodgkin lymphoma-historical aspects on the precautionary principle in cancer prevention. Acta Oncol 2008, 47(3):347-354.
73. Andrade FH, Figueiroa FC, Bersano PR, et al. Malignant mammary tumor in female dogs: environmental contaminants. Diagn Pathol 2010, 5:45.
74. Zahm SH, Blair A Pesticides and non-Hodgkin's lymphoma. Cancer Res 1992, 52(19 Suppl):5485s-5488s.
75. Garabrant DH, Philbert MA Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology. Crit Rev Toxicol 2002, 32(4):233-257.
76. Hayes HM, Tarone RE, Cantor KP On the association between canine malignant lymphoma and opportunity for exposure to 2,4-dichlorophenoxyacetic acid. Environ Res 1995, 70(2):119-125.
77. Comba P, Bianchi F, Fazzo L, et al. Cancer mortality in an area of Campania (Italy) characterized by multiple toxic dumping sites. Ann N Y Acad Sci 2006, 1076:449-461.
78. Upton AC, Kneip T, Toniolo P Public health aspects of toxic chemical disposal sites. Annu Rev Public Health 1989, 10:1-25.
79. Vrijheid M Health effects of residence near hazardous waste landfill sites: a review of epidemiologic literature. Environ Health Perspect 2000, 108(Suppl 1):101-112.
80. Dosemeci M, Wacholder S, Lubin JH Does nondifferential misclassification of exposure always bias a true effect toward the null value?. Am J Epidemiol 1990, 132(4):746-748.
81. Wacholder S, Hartge P, Lubin JH, et al. Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med 1995, 52(8):557-558.
82. Millanta F, Calandrella M, Bari G, et al. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci 2005, 79(3):225-232.
83. Rhodes L, Ding VD, Kemp RK, et al. Estradiol causes a dose-dependent stimulation of prostate growth in castrated beagle dogs. Prostate 2000, 44(1):8-18.
84. Perez Alenza MD, Pena L, del Castillo N, et al. Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract 2000, 41(7):287-291.
85. Heinlein CA, Chang C Androgen receptor in prostate cancer. Endocr Rev 2004, 25(2):276-308.
86. Gann PH, Hennekens CH, Ma J, et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996, 88(16):1118-1126.
87. Johnston SD, Kamolpatana K, Root-Kustritz MV, et al. Prostatic disorders in the dog. Anim Reprod Sci 2000, 60-61:405-415.
88. Sorenmo KU, Goldschmidt M, Shofer F, et al. Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time. Vet Comp Oncol 2003, 1(1):48-56.
89. Navarro D, Luzardo OP, Fernandez L, et al. Transition to androgen-independence in prostate cancer. J Steroid Biochem Mol Biol 2002, 81(3):191-201.
90. Martano M, Morello E, Buracco P Feline injection-site sarcoma: past, present and future perspectives. Vet J 2011, 188(2):136-141.
91. Kass PH Methodological issues in the design and analysis of epidemiological studies of feline vaccine-associated sarcomas. Anim Health Res Rev 2004, 5(2):291-293.
92. Magden E, Quackenbush SL, Vandewoude S FIV associated neoplasms-A mini-review. Vet Immunol Immunopathol 2011, 143(3-4):227-234.
93. Yamamoto JK, Hansen H, Ho EW, et al. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989, 194(2):213-220.
94. Rezanka LJ, Rojko JL, Neil JC Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest 1992, 10(5):371-389.
95. Bossuyt PM, Reitsma JB The STARD initiative. Lancet 2003, 361(9351):71.
96. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003, 49(1):1-6.
97. Gardner IA Quality standards are needed for reporting of test accuracy studies for animal diseases. Prev Vet Med 2010, 97(3-4):136-143.
98. Webster JD, Dennis MM, Dervisis N, et al. Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology. Vet Pathol 2011, 48(1):7-18.
99. Lawrence J, Rohren E, Provenzale J PET/CT today and tomorrow in veterinary cancer diagnosis and monitoring: fundamentals, early results and future perspectives. Vet Comp Oncol 2010, 8(3):163-187.
100. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011, 155(11):762-771.
101. Sargeant JM, Thompson A, Valcour J, et al. Quality of reporting of clinical trials of dogs and cats and associations with treatment effects. J Vet Intern Med 2010, 24(1):44-50.
102. Vail DM Cancer clinical trials: development and implementation. Vet Clin North Am Small Anim Pract 2007, 37(6):1033-1057.
103. London CA, Malpas PB, Wood-Follis SL, et al. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. Clin Cancer Res 2009, 15(11):3856-3865.
104. Rau SE, Barber LG, Burgess KE Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs. J Vet Intern Med 2010, 24(6):1452-1457.
105. Scott MC, Sarver AL, Gavin KJ, et al. Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach. Bone 2011, 49(3):356-367.
106. Modiano JF, Breen M, Burnett RC, et al. Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 2005, 65(13):5654-5661.
107. Akesson A, Julin B, Wolk A Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res 2008, 68(15):6435-6441.
108. Shaw J Chapter 15c: Relationship-Centered Approach to Cancer Communication. Small Animal Clinical Oncology 2012, Saunders Elsevier, St. Louis. S.J. Withrow, E.G. MacEwen, R.L. Page (Eds.).